![Alyssa Levin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alyssa Levin
Financieel Directeur/CFO bij NKARTA, INC.
Vermogen: - $ op 31-05-2024
Profiel
Alyssa Levin is currently the Chief Financial & Business Officer at Nkarta, Inc. She previously worked as the Chief Financial Officer at ViaCyte, Inc. and Bird Rock Bio Sub, Inc. She also served as the Chief Financial Officer & Senior VP-Operations at Tentarix Biotherapeutics, Inc. Ms. Levin completed her undergraduate degree at the University of British Columbia and her graduate degree at Edwards School of Business.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
NKARTA, INC.
-.--% | 15-04-2024 | 0 ( -.--% ) | - $ | 31-05-2024 |
Actieve functies van Alyssa Levin
Bedrijven | Functie | Begin |
---|---|---|
NKARTA, INC. | Financieel Directeur/CFO | 05-07-2023 |
Eerdere bekende functies van Alyssa Levin
Bedrijven | Functie | Einde |
---|---|---|
ViaCyte, Inc.
![]() ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Financieel Directeur/CFO | 05-07-2023 |
Tentarix Biotherapeutics, Inc. | Financieel Directeur/CFO | 02-01-2022 |
Bird Rock Bio, Inc.
![]() Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA. | Financieel Directeur/CFO | 02-01-2020 |
Opleiding van Alyssa Levin
University of British Columbia | Undergraduate Degree |
Edwards School of Business | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
NKARTA, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
ViaCyte, Inc.
![]() ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Health Technology |
Bird Rock Bio, Inc.
![]() Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA. | Health Technology |
Tentarix Biotherapeutics, Inc. |